Nucala 100 MG/ML auto-injectorml
Ended Awarded
- Contract number
- SPE2DB25FPQR6
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $28,394
Award facts
- Contract value 100% obligated
- $28,393.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On June 2, 2025, the Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $28,393.50 to DMS Pharmaceutical Group Inc. for the supply of Nucala 100 mg/ml auto-injectors. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park Ridge facility. This delivery order was issued without a set-aside designation, allowing the vendor to compete on an open basis despite its small business status. The ultimate completion date for this order is June 3, 2025.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, a $499,999,999 single-award contract valid through November 2026. The IDC enables DLA to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support the medical supply needs of Department of Defense healthcare facilities worldwide. As a key supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has established a robust track record delivering specialized pharmaceutical products including auto-injectors, vaccines, oncology treatments, and other critical medications to military health facilities.
Quick answers
Who was awarded contract SPE2DB25FPQR6?
SPE2DB25FPQR6 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 2, 2025.
How much is contract SPE2DB25FPQR6 worth?
The government has obligated $28,394 on SPE2DB25FPQR6.
Is contract SPE2DB25FPQR6 an order under another contract?
Yes. SPE2DB25FPQR6 is a delivery order under SPE2DB20D9127, an indefinite delivery contract.
Was contract SPE2DB25FPQR6 competed?
The extent of competition for SPE2DB25FPQR6 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award